Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BIAF
BIAF
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BIAF News
CyPath®Lung Sales Surge Nearly 300% in April 2026
May 12 2026
Newsfilter
bioAffinity Technologies Reports Q1 Financial Results
May 08 2026
seekingalpha
CyPath® Lung Diagnostic Sales Surge 146% Year-Over-Year
May 08 2026
Newsfilter
BIOAFFINITY TECHNOLOGIES INC REPORTS 27% DROP IN TOTAL CONSOLIDATED REVENUE TO $1.4 MILLION FOR Q1 2026
May 08 2026
moomoo
BIOAFFINITY TECHNOLOGIES INC REPORTS Q1 2026 NET LOSS OF $3.6 MILLION, EQUIVALENT TO $0.81 PER SHARE
May 08 2026
moomoo
bioAffinity Partners with Military Medical Center to Develop Respiratory Disease Diagnostics
Apr 28 2026
Newsfilter
bioAffinity Technologies' CyPath Lung Test Surpasses Sales Expectations
Apr 01 2026
stocktwits
Urban-Gro Merges with Flash Sports, Expands into Media Sector
Mar 31 2026
stocktwits
BioAffinity's CyPath Lung Test Shows Promising Results and Sales Growth
Mar 23 2026
stocktwits
BIAF Shares Jump 85%, Exceed 200-DMA for the First Time in Almost a Year – Here's What's Fueling the Surge
Mar 23 2026
stocktwits
bioAffinity Technologies Launches New Lung Cancer Test Case Study
Mar 17 2026
NASDAQ.COM
BioAffinity Technologies Shares Surge 20% on Positive CyPath Lung Test Results
Mar 17 2026
stocktwits
bioAffinity Technologies 2025 Financial Overview
Mar 13 2026
seekingalpha
bioAffinity Technologies Stock Soars on Strong CyPath Lung Results
Mar 13 2026
Benzinga
bioAffinity Technologies Shares Surge 72% on Lung Cancer Study Announcement
Mar 13 2026
NASDAQ.COM
U.S. Stocks Rise in Morning Trade Amid Economic Slowdown
Mar 13 2026
Benzinga
Show More News
